116 related articles for article (PubMed ID: 12432550)
1. Cell-free 27 kDa heat shock protein (hsp27) and hsp27-cytochrome c complexes in the cervix of women with ovarian or endometrial cancer.
Korneeva I; Caputo TA; Witkin SS
Int J Cancer; 2002 Dec; 102(5):483-6. PubMed ID: 12432550
[TBL] [Abstract][Full Text] [Related]
2. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
[TBL] [Abstract][Full Text] [Related]
3. IgA antibodies to the 27-kDa heat-shock protein in the genital tracts of women with gynecologic cancers.
Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
Int J Cancer; 2000 Sep; 87(6):824-8. PubMed ID: 10956393
[TBL] [Abstract][Full Text] [Related]
4. Are IgG antibodies to heat shock proteins HSP27 and HSP60 useful markers in endometrial cancer and cervical cancer?
Bodzek P; Szymala B; Damasiewicz-Bodzek A; Janosz I; Witek L; Olejek A
Ginekol Pol; 2021; 92(11):760-766. PubMed ID: 33914318
[TBL] [Abstract][Full Text] [Related]
5. Hsp27 negatively regulates cell death by interacting with cytochrome c.
Bruey JM; Ducasse C; Bonniaud P; Ravagnan L; Susin SA; Diaz-Latoud C; Gurbuxani S; Arrigo AP; Kroemer G; Solary E; Garrido C
Nat Cell Biol; 2000 Sep; 2(9):645-52. PubMed ID: 10980706
[TBL] [Abstract][Full Text] [Related]
6. Expression of the heat shock protein HSP27 in human ovarian cancer.
Langdon SP; Rabiasz GJ; Hirst GL; King RJ; Hawkins RA; Smyth JF; Miller WR
Clin Cancer Res; 1995 Dec; 1(12):1603-9. PubMed ID: 9815962
[TBL] [Abstract][Full Text] [Related]
7. Hsp27 as a prognostic and predictive factor in cancer.
Ciocca DR; Vargas-Roig LM
Prog Mol Subcell Biol; 2002; 28():205-18. PubMed ID: 11908061
[No Abstract] [Full Text] [Related]
8. A study of heat shock protein 27 in endometrial carcinoma.
Geisler JP; Geisler HE; Tammela J; Miller GA; Wiemann MC; Zhou Z
Gynecol Oncol; 1999 Mar; 72(3):347-50. PubMed ID: 10053106
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of antibodies against heat shock protein 27 in the sera of women with ovarian carcinoma.
Olejek A; Damasiewicz-Bodzek A; Bodzek P; Wielkoszyński T; Zamłyński J; Stołtny P; Skutil M
Int J Gynecol Cancer; 2009 Dec; 19(9):1516-20. PubMed ID: 19955928
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
11. Heat-shock proteins as death determinants.
Xanthoudakis S; Nicholson DW
Nat Cell Biol; 2000 Sep; 2(9):E163-5. PubMed ID: 10980714
[No Abstract] [Full Text] [Related]
12. HSP27 is required for invasion and metastasis triggered by hepatocyte growth factor.
Pavan S; Musiani D; Torchiaro E; Migliardi G; Gai M; Di Cunto F; Erriquez J; Olivero M; Di Renzo MF
Int J Cancer; 2014 Mar; 134(6):1289-99. PubMed ID: 23996744
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein expression and immunity: relevance to gynecologic oncology.
Witkin SS
Eur J Gynaecol Oncol; 2001; 22(4):249-56. PubMed ID: 11695802
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein 27: a potential biomarker of peritoneal metastasis in epithelial ovarian cancer?
Zhao M; Ding JX; Zeng K; Zhao J; Shen F; Yin YX; Chen Q
Tumour Biol; 2014 Feb; 35(2):1051-6. PubMed ID: 24061637
[TBL] [Abstract][Full Text] [Related]
15. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance.
Kapranos N; Kominea A; Konstantinopoulos PA; Savva S; Artelaris S; Vandoros G; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2002 Aug; 128(8):426-32. PubMed ID: 12200599
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein 27 (HSP27) in patients with ovarian cancer.
Bodzek P; Damasiewicz-Bodzek A; Janosz I; Witek L; Olejek A
Ginekol Pol; 2021; 92(12):837-843. PubMed ID: 34105741
[TBL] [Abstract][Full Text] [Related]
17. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
[TBL] [Abstract][Full Text] [Related]
18. Shed membrane fragment-associated markers for endometrial and ovarian cancers.
Taylor DD; Lyons KS; Gerçel-Taylor C
Gynecol Oncol; 2002 Mar; 84(3):443-8. PubMed ID: 11855885
[TBL] [Abstract][Full Text] [Related]
19. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
Hall KL; Dewar MA; Perchalski J
Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
[TBL] [Abstract][Full Text] [Related]
20. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3.
Pandey P; Farber R; Nakazawa A; Kumar S; Bharti A; Nalin C; Weichselbaum R; Kufe D; Kharbanda S
Oncogene; 2000 Apr; 19(16):1975-81. PubMed ID: 10803458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
